FIELD: medicine.
SUBSTANCE: invention relates to a preservative pharmaceutical composition for glaucoma or ocular hypertension treatment, which comprises dorsolamide or its pharmaceutically acceptable salt and brimonidine or its pharmaceutically acceptable salt, does not contain a preservative other than edetic acid or its salt selected from the group which includes edetate monosodium, edetate disodium and edetate tetrasodium, and boracic acid or its salt selected from group consisting of borax, sodium borate and potassium borate, where: edetic acid or its salt mass content varies from 0,001% mass/vol to 0,1% mass/vol; boracic acid or its salt content varies from 0,001% mass/vol to 3% mass/vol; and pH is 6.0 or more. Present invention also relates to eye drops for glaucoma or ocular hypertension treatment, to the preservative pharmaceutical composition usage, and to a method for increasing preservative effectiveness.
EFFECT: receiving a composition with a sufficient preservative effect.
14 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ANTIMICROBIAL METAL | 2014 |
|
RU2666961C2 |
ANTISEPTIC, INCLUDING MEGLUMINE OR ITS SALT | 2017 |
|
RU2745617C2 |
DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ZINC | 2014 |
|
RU2675813C2 |
AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
PHARMACEUTICAL COMPOSITIONS POSSESSING DESIRABLE BIOAVAILABILITY | 2009 |
|
RU2503453C2 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
METHOD FOR SUPPRESSING DECREASE IN VISCOSITY OF AQUEOUS LIQUID AGENT | 2012 |
|
RU2598721C2 |
OPHTHALMIC COMPOSITION WITH VISCOSITY ENHANCEMENT SYSTEM HAVING TWO DIFFERENT VISCOSITY ENHANCING AGENTS | 2012 |
|
RU2601115C2 |
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE | 2014 |
|
RU2687551C2 |
Authors
Dates
2021-03-23—Published
2017-02-21—Filed